Search Results - "Jurgensen, H J"

Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study by Dubertret, L, Wallach, D, Souteyrand, P, Perussel, M, Kalis, B, Meynadier, J, Chevrant-Breton, J, Beylot, C, Bazex, J A, Jurgensen, H J

“…The biologically active form of vitamin D3, calcitriol, may offer a new therapeutic approach to psoriasis. Calcipotriol, a new vitamin D3 analogue, is at least…”
Get more information

Registration of diagnoses in the Danish National Registry of Patients by Jürgensen, H J, Frølund, C, Gustafsen, J, Mosbech, H, Guldhammer, B, Mosbech, J

Get more information

Comparative effects of pinacidil and nifedipine in the treatment of arterial hypertension by Jürgensen, H J

Get full text

Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol by Jürgensen, J H, Frederiksen, J, Hansen, D A, Pedersen-Bjergaard, O

“…Two hundred and eighty-two patients less than 66 years of age admitted with suspected or definite myocardial infarction were allocated in a random fashion to…”
Get full text

A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis by Berth-Jones, J, Chu, A C, Dodd, W A, Ganpule, M, Griffiths, W A, Haydey, R P, Klaber, M R, Murray, S J, Rogers, S, Jurgensen, H J

“…Short-contact treatment with dithranol (anthralin) is a widely used treatment for chronic plaque psoriasis. Although effective, it causes staining and…”
Get more information

Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease by Perrild, H, Pedersen, F, Rasmussen, S L, Jürgensen, H J, Skovsted, L

“…After treatment with alprenolol for 1 year, serum 3,3',5'-triiodothyronine (rT3) was significantly increased (P less than 0.01) in a group (n = 20) of…”
Get more information

Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease by Jürgensen, H J, Dalsgaard-Nielsen, J, Kjøller, E, Gormsen, J

“…In 14 patients with coronary heart disease the effect of long-term treatment (mean 16 months, range 12-33) with alprenolol on platelet function and…”
Get full text

Lack of effect of intravenous LHRH on plasma noradrenaline in man by Jürgensen, H J, Christensen, N J, Ladefoged, S, Micic, S

“…One hundred microgram of LHRH was given intravenously to two male and two female subjects. Plasma noradrenaline did not change following LHRH, in contrast to…”
Get more information

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results by Andersen, M P, Bechsgaard, P, Frederiksen, J, Hansen, D A, Jürgensen, H J, Nielsen, B, Pedersen, F, Pedersen-Bjergaard, O, Rasmussen, S L

“…A double-blind study of alprenolol versus placebo was done in patients with definite or suspected myocardial infarction to show the effect of the drug on…”
Get more information

The long-term effect of alprenolol on plasma apolipoproteins A-I and B by Gerdes, L U, Jürgensen, H J, Groot, P H, Faergeman, O

“…The concentration of lipids, lipoproteins and apolipoprotein A-I and B was measured in the plasma of 33 patients, enrolled in a double-blind, controlled trial…”
Get more information

Oxyhaemoglobin equilibrium and chronic beta‐adrenoceptor blockade in coronary heart disease by Jurgensen, HJ, Wimberley, PD, Brodthagen, U

“…In 20 patients with coronary heart disease the effect of long‐term beta‐ adrenergic receptor blockade on the haemoglobin oxygen equilibrium was investigated…”
Get full text

Plasma lipids and lipoproteins in long-term beta-adrenergic blockade by Jürgensen, H J, Meinertz, H, Faergeman, O

Get more information

The Efficacy of Inosine Pranobex in Preventing the Acquired Immunodeficiency Syndrome in Patients with Human Immunodeficiency Virus Infection by Pedersen, Court, Sandström, Eric, Petersen, Carsten Sand, Norkrans, Gunnar, Gerstoft, Jan, Karlsson, Anders, Christensen, Knud Chr, Håkansson, Charles, Pehrson, PehrOlov, Nielsen, Jens Ole, Jürgensen, Hans Jessen

“…We performed a randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of inosine pranobex (isoprinosine) in the treatment of…”
Get full text

The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction by Jürgensen, H J, Frederiksen, J, Andersen, M P, Bechsgaard, P, Hansen, D A, Nielsen, P B, Pedersen, F, Pedersen-Bjergaard, O, Rasmussen, S L

Get more information

Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study by Jürgensen, H J

Get more information

Online condition mointoring of circuit breakers for failure prediction: a case study by Jürgensen, J. H., Bohm, H., Hansson, C., Sollèn, M., Norström, A.

“…Circuit breakers control and protect the power system by providing the vital functions manoeuvrability, load breaking capability, and current carrying. A loss…”
Get full text

Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group by Fletcher, A E, Battersby, C, Adnitt, P, Underwood, N, Jurgensen, H J, Bulpitt, C J

“…The quality of life (QL) was evaluated in a 6 month double-blind trial in six European countries. Patients with a sustained supine diastolic blood pressure…”
Get more information

Registration of diagnoses in a national patient register. Preliminary assessment of the validity of the register by Jürgensen, H J, Frølund, C, Gustafsen, J, Mosbech, H, Guldhammer, B

Get more information

Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths by Hansen, D A, Jürgensen, H J, Pedersen-Bjergaard, O

Get more information

Use of beta-blockers in the secondary prevention of acute myocardial infarcts. Status and recomendations by Jurgensen, H J

Get more information